Inflammatory markers
Inflammatory markers is an intervention with 9 clinical trials. Currently 3 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
3
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Regulation of Inflammatory Genes in Psoriasis
Relation Between Inflammatory Responses and Sequelae of Pediatric Corrosive Ingestion Cases in Assiut
Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis
PET/MR in Post Stroke Cardiac Inflammation Study
Clinical Trials (9)
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Regulation of Inflammatory Genes in Psoriasis
Relation Between Inflammatory Responses and Sequelae of Pediatric Corrosive Ingestion Cases in Assiut
Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis
PET/MR in Post Stroke Cardiac Inflammation Study
Evaluation of Inflammatory Markers in LARC Patients
Role of Inflammation in Carpal Tunnel Syndrome
Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Strain and Blood Inflammatory Markers as Prognostic Tools for ARDS AMIS (ARDS - Markers of Inflammation - Strain)
All 9 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 9